Trump promotes cheaper meds but new rules threaten

The Trump administration delayed a new customs rule that would require detailed packaging, tariffs, and paperwork for imported prescription drugs, aiming to prevent disruptions in access to affordable medications for Americans. The regulation, originally set to start soon, faced opposition from advocacy groups and patients who fear it will hinder personal importation of essential drugs, especially as many rely on overseas pharmacies due to high domestic prices. The delay until January 20 aims to avoid immediate supply interruptions, but concerns persist about the rule's long-term impact on the availability of imported medications.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل